ES531995A0 - Formulacion parenteral de nimodipina, un procedimiento para su preparacion, asi como su empleo en la lucha contra enfermedades - Google Patents

Formulacion parenteral de nimodipina, un procedimiento para su preparacion, asi como su empleo en la lucha contra enfermedades

Info

Publication number
ES531995A0
ES531995A0 ES531995A ES531995A ES531995A0 ES 531995 A0 ES531995 A0 ES 531995A0 ES 531995 A ES531995 A ES 531995A ES 531995 A ES531995 A ES 531995A ES 531995 A0 ES531995 A0 ES 531995A0
Authority
ES
Spain
Prior art keywords
weight
nimodipine
parenteral formulation
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES531995A
Other languages
English (en)
Spanish (es)
Other versions
ES8505542A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8505542A1 publication Critical patent/ES8505542A1/es
Publication of ES531995A0 publication Critical patent/ES531995A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
ES531995A 1983-05-06 1984-04-27 Formulacion parenteral de nimodipina, un procedimiento para su preparacion, asi como su empleo en la lucha contra enfermedades Granted ES531995A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833316510 DE3316510A1 (de) 1983-05-06 1983-05-06 Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen

Publications (2)

Publication Number Publication Date
ES8505542A1 ES8505542A1 (es) 1985-06-01
ES531995A0 true ES531995A0 (es) 1985-06-01

Family

ID=6198265

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531995A Granted ES531995A0 (es) 1983-05-06 1984-04-27 Formulacion parenteral de nimodipina, un procedimiento para su preparacion, asi como su empleo en la lucha contra enfermedades

Country Status (19)

Country Link
US (1) US5114956A (ref)
EP (1) EP0126315B1 (ref)
JP (1) JPS59206305A (ref)
KR (1) KR920000306B1 (ref)
AT (1) ATE24835T1 (ref)
AU (1) AU562293B2 (ref)
BE (1) BE899564A (ref)
CA (1) CA1220424A (ref)
DE (2) DE3316510A1 (ref)
DK (1) DK164148C (ref)
ES (1) ES531995A0 (ref)
FR (1) FR2545354B1 (ref)
GR (1) GR81609B (ref)
HK (1) HK75889A (ref)
IL (1) IL71744A (ref)
IT (1) IT1181804B (ref)
PT (1) PT78542B (ref)
SG (1) SG44489G (ref)
ZA (1) ZA843352B (ref)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
AT387518B (de) * 1985-12-18 1989-02-10 Bayer Ag Verfahren zur herstellung von fluessigen spruehpraeparaten von dihydropyridinen
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
DE3702105A1 (de) * 1987-01-24 1988-08-04 Bayer Ag Parenterale loesung
BE1003647A5 (fr) * 1989-02-28 1992-05-12 Syntex Inc Composition pharmaceutique de nicardipine pour administration parenterale.
RU1804845C (ru) * 1991-02-15 1993-03-30 Институт Органического Синтеза Латвийской Ан Ноотропное вещество
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
JPH10510540A (ja) 1994-12-12 1998-10-13 オメロス メディカル システムズ，インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
EP2301562B1 (en) * 1994-12-12 2013-04-17 Omeros Corporation Irrigation solution and method for inhibition of pain, inflammation and spasm
US6413961B1 (en) 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
US8034762B2 (en) * 2004-09-02 2011-10-11 Cognosci, Inc. Treatment of subarachnoid hemorrhage with Apo E analogs
US20070117851A1 (en) * 2005-10-14 2007-05-24 Transform Pharmaceuticals, Inc. Liquid pharmaceutical compositions of nimodipine
WO2007125028A1 (de) * 2006-04-28 2007-11-08 Basf Se Verfahren zur solubilisierung von hydrophoben wirkstoffen in wässrigem medium
US8728504B2 (en) 2010-02-05 2014-05-20 Basf Se Process for solubilizing hydrophobic active ingredients in aqueous medium
CN102741327B (zh) 2010-02-05 2014-11-05 巴斯夫欧洲公司 在水溶液中加溶疏水性活性成分的方法
AU2012250050B2 (en) 2011-04-28 2017-04-06 Platform Brightworks Two, Ltd. Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
US10092553B2 (en) 2016-04-13 2018-10-09 Nortic Holdings Inc. Stable nimodipine parenteral formulation
BR112018070960A2 (pt) 2016-04-13 2019-01-29 Nortic Holdings Inc. formulação parenteral de nimodipina estável
EP3755326A4 (en) 2018-02-22 2021-11-03 Nortic Holdings Inc. STABLE PARENTERAL FORMULATION OF NIMODIPINE
CN119300828A (zh) 2022-05-16 2025-01-10 美国阿卡斯蒂制药股份有限公司 尼莫地平肠胃外给药
CN117502433A (zh) * 2023-11-08 2024-02-06 中国科学院海洋研究所 一种水母刺丝囊存放保护剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2650013C3 (de) * 1976-10-30 1981-04-02 Bayer Ag, 5090 Leverkusen 1.4-Dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsäureisopropyl-(2-propoxy-äthyl)-ester, Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE2841667A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
IT1181804B (it) 1987-09-30
DK224184A (da) 1984-11-07
BE899564A (fr) 1984-11-05
PT78542A (en) 1984-06-01
SG44489G (en) 1989-11-17
IT8448139A0 (it) 1984-05-04
ES8505542A1 (es) 1985-06-01
DK164148B (da) 1992-05-18
PT78542B (en) 1986-07-14
HK75889A (en) 1989-09-29
EP0126315B1 (de) 1987-01-14
KR920000306B1 (ko) 1992-01-11
ATE24835T1 (de) 1987-01-15
JPH0422888B2 (ref) 1992-04-20
AU562293B2 (en) 1987-06-04
DE3316510A1 (de) 1984-11-08
EP0126315A1 (de) 1984-11-28
KR840009031A (ko) 1984-12-24
FR2545354B1 (fr) 1986-09-26
AU2758384A (en) 1984-11-08
JPS59206305A (ja) 1984-11-22
IT8448139A1 (it) 1985-11-04
US5114956A (en) 1992-05-19
IL71744A0 (en) 1984-09-30
DK164148C (da) 1992-10-26
ZA843352B (en) 1984-12-24
FR2545354A1 (fr) 1984-11-09
IL71744A (en) 1988-04-29
DE3461988D1 (en) 1987-02-19
CA1220424A (en) 1987-04-14
DK224184D0 (da) 1984-05-04
GR81609B (ref) 1984-12-11

Similar Documents

Publication Publication Date Title
ES531995A0 (es) Formulacion parenteral de nimodipina, un procedimiento para su preparacion, asi como su empleo en la lucha contra enfermedades
ATE100484T1 (de) Lagerstabile aufhellerformulierung.
ES2150989T3 (es) Nuevos derivados de quinoxalinadiona, su preparacion y empleo en medicamentos.
MX17808A (es) Nuevos derivados de artemisinina,procedimiento para su preparacion y su uso como agentes antiprosoos
ATE93678T1 (de) Mikrobiozide jodzusammensetzung.
JPS57156413A (en) Antimycotic
ES2154311T3 (es) Quinoxalinas, procedimiento para su preparacion y su utilizacion.
BG50483A3 (bg) Хербициден състав и метод за борба с нежелана растителност
ATE120611T1 (de) Pflanzenschutz-mikroemulsionszusammensetzung.
GB2003731A (en) The use of imidazole derivatives as fungicides
ES2051939T3 (es) Heteroaromatos fenoxialquilsubstituidos, procedimientos para su obtencion y su empleo para la lucha contra las pestes.
CO5040014A1 (es) Mezclas fungicidas
JPS5750914A (en) Betamethasone external pharmaceutical
ES2093651T3 (es) Purinas sustituidas, procedimiento para su preparacion asi como su empleo como agentes antiviricos.
BR8203379A (pt) Composicoes herbicidas baseadas em derivados de cloro-aceto-ciclo-alquil-amidas
DE3872391D1 (de) Fungizide zusammensetzungen.
IT8022601A0 (it) Derivati 3h-naft[1.2-d]-imidazolici il procedimento per la loro preparazione,il loro uso come agenti antiinfiammatori e le composizioni farmaceutiche che li contengono
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
MX9204118A (es) 2-amino-1,3,4,-tiadiazoles aminoalquilsustituidos, su preparacion y su empleo.
JPS5350328A (en) Composition for herbicides
MX9204116A (es) 2-amino-5-mercaptotiadizoles, aminoalquilsustituidos su preparacion y su empleo.
MX9300890A (es) Nuevos pirazolilpirazoles substituidos, su elaboracion asi como productos intermedios para su elaboracion y, su empleo como agentes con efecto herbicida.
TH12664A (th) องค์ประกอบของเครื่องสำอาง
AR227502A1 (es) -n,n'-metilen-bis-(0,0-diaril-n-fosfonometilglioinonitrilos)utiles como herbicidas,composiciones herbicidas que los contienen y procedimiento para la preparacion de dichos compuestos
NO900951L (no) Pulversammensetning for aa lage munnvann.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050307